{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:58:19Z","timestamp":1767985099153,"version":"3.49.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["A2084c0159"],"award-info":[{"award-number":["A2084c0159"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immunoglobulin G (IgG) monoclonal antibodies dominate current cancer immunotherapy but face challenges including resistance development, limited tumor penetration, and suboptimal avidity. In contrast, the pentameric or hexameric architecture of immunoglobulin M (IgM) offers up to twelve antigen-binding sites and potent complement activation, positioning IgM as a promising next-generation therapeutic scaffold. Here, we present integrative structural modeling and multiscale molecular dynamics simulations of IgM versions of Cetuximab and Matuzumab targeting the epidermal growth factor receptor (EGFR), a clinically validated oncogenic driver. Our analyses reveal that IgM antibodies maintain a rigid, glycan-stabilized Fc core while their Fab domains exhibit high mobility, enabling multivalent EGFR binding. Compared with IgG, IgM antibodies demonstrated enhanced binding avidity, prolonged receptor engagement, and slower dissociation kinetics. These properties suggest superior therapeutic durability and potential to overcome current limitations of IgG-based therapies. By providing mechanistic insight into how IgM isotypes can improve therapeutic engagement with tumor-associated antigens, our study supports the development of IgM antibodies as a new class of cancer immunotherapies.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1733907","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:38:05Z","timestamp":1767940685000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the epidermal growth factor receptor using IgM antibodies: toward next generation cancer immunotherapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Kamolrat","family":"Somboon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Bond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firdaus","family":"Samsudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3236","article-title":"Antibody therapy of cancer","volume":"12","author":"Scott","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2744","article-title":"Monoclonal antibodies: versatile platforms for cancer immunotherapy","volume":"10","author":"Weiner","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrd.2017.227","article-title":"Next generation antibody drugs: pursuit of the \u2018high-hanging fruit,\u2019","volume":"17","author":"Carter","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111597","article-title":"Cancer-cell-derived igG and its potential role in tumor development","volume":"22","author":"Kdimati","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.15252\/embr.202153956","article-title":"Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch","volume":"23","author":"Callegari","year":"2022","journal-title":"EMBO Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"10180","DOI":"10.1038\/s41598-018-28242-y","article-title":"Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro","volume":"8","author":"Devito","year":"2018","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044927","article-title":"The anti-cancer igM monoclonal antibody PAT-SM6 binds with high avidity to the unfolded protein response regulator GRP78","volume":"7","author":"Rosenes","year":"2012","journal-title":"PloS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41573-019-0028-1","article-title":"Bispecific antibodies: a mechanistic review of the pipeline","volume":"18","author":"Labrijn","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40164-021-00250-1","article-title":"Recent advances and challenges of bispecific antibodies in solid tumors","volume":"10","author":"Wu","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12935-023-02902-0","article-title":"Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired","volume":"23","author":"Marei","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","article-title":"Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities","volume":"151","author":"Gonzalez-Quintela","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00099","article-title":"Emerging functions of natural igM and its fc receptor FCMR in immune homeostasis","volume":"7","author":"Wang","year":"2016","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(89)90244-2","article-title":"IgM - molecular requirements for its assembly and function","volume":"10","author":"Davis","year":"1989","journal-title":"Immunol Today"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90313-1","article-title":"IgM hexamers","volume":"15","author":"Brewer","year":"1994","journal-title":"Immunol Today"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002371","article-title":"Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities","volume":"3","author":"Polonelli","year":"2008","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0903805106","article-title":"The human IgM pentamer is a mushroom-shaped molecule with a flexural bias","volume":"106","author":"Czajkowsky","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1987.tb02569.x","article-title":"Polymeric immunoglobulin M is secreted by transfectants of non-lymphoid cells in the absence of immunoglobulin J chain","volume":"6","author":"Cattaneo","year":"1987","journal-title":"EMBO J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.7.2884","article-title":"Polymer IgM assembly and secretion in lymphoid and nonlymphoid cell lines: evidence that J chain is required for pentamer IgM synthesis","volume":"92","author":"Niles","year":"1995","journal-title":"Proc Natl Acad Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2013.06.033","article-title":"EGFR overexpressing cells and tumors are dependent on autophagy for growth and survival","volume":"108","author":"Jutten","year":"2013","journal-title":"Radiotherapy Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2015.12.006","article-title":"Stress-induced EGFR trafficking: mechanisms, functions, and therapeutic implications","volume":"26","author":"Tan","year":"2016","journal-title":"Trends Cell Biol"},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer","volume-title":"Mol Oncol","author":"Sigismund","year":"2018"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.02.019","article-title":"Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization","volume":"13","author":"Schmiedel","year":"2008","journal-title":"Cancer Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.06.003","article-title":"Cetuximab: An epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer","volume":"27","author":"Wong.","year":"2005","journal-title":"Clin Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1039\/c9sc04722k","article-title":"Not all therapeutic antibody isotypes are equal: The case of IgM: Versus IgG in Pertuzumab and Trastuzumab","volume":"11","author":"Samsudin","year":"2020","journal-title":"Chem Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz5425","article-title":"Structural insights into immunoglobulin M","volume":"367","author":"Li","year":"2020","journal-title":"Science"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1021\/bp040016j","article-title":"Glycosylation of recombinant antibody therapeutics","volume-title":"Biotechnol Progress","author":"Jefferis.","year":"2005"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1812833115","article-title":"Site-selective chemoenzymatic glycoengineering of Fab and Fc glycans of a therapeutic antibody","volume":"115","author":"Giddens","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-62703-327-5_7","article-title":"Cetuximab fab and fc N-glycan fast characterization using ideS digestion and liquid chromatography coupled to electrospray ionization mass spectrometry","volume-title":"Biotechnol Progress","author":"Janin-Bussat","year":"2013"},{"key":"B29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ab.2007.01.023","article-title":"Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption\/ionization hybrid quadrupole\u2013quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion","volume":"364","author":"Qian","year":"2007","journal-title":"Anal Biochem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M504528200","article-title":"Human serum IgM glycosylation: Identification of glycoforms that can bind to Mannan-binding lectin","volume":"280","author":"Arnold","year":"2005","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34090-2","article-title":"Cryomicroscopy reveals the structural basis for a flexible hinge motion in the immunoglobulin M pentamer","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.12.067","article-title":"Architecture of human igM in complex with P. falciparum erythrocyte membrane protein 1","volume":"14","author":"Akhouri","year":"2016","journal-title":"Cell Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/srep08926","article-title":"Effects of N-glycosylation on protein conformation and dynamics: Protein Data Bank analysis and molecular dynamics simulation study","volume":"5","author":"Lee","year":"2015","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijms.2010.08.003","article-title":"Effects of glycosylation on the stability and flexibility of a metastable protein: The human serpin \u03b11-antitrypsin","volume":"302","author":"Sarkar","year":"2011","journal-title":"Int J Mass Spectrom"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.3.6.17922","article-title":"The impact of glycosylation on monoclonal antibody conformation and stability","volume":"3","author":"Zheng","year":"2011","journal-title":"MAbs"},{"key":"B36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/imm.13481","article-title":"Therapeutic antibody glycosylation impacts antigen recognition and immunogenicity","volume":"166","author":"Wolf","year":"2022","journal-title":"Immunology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24444","article-title":"Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and fc-fusion proteins","volume":"104","author":"Liu.","year":"2015","journal-title":"J Pharm Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.str.2021.01.002","article-title":"Structure of the human secretory immunoglobulin M core","volume":"29","author":"Kumar","year":"2021","journal-title":"Structure"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-023-00985-x","article-title":"Tolar and P. B. Rosenthal., Structural basis for Fc receptor recognition of immunoglobulin M","volume":"30","author":"Chen","year":"2023","journal-title":"Nat Struct Mol Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/19420862.2018.1522178","article-title":"Antigen binding allosterically promotes Fc receptor recognition","volume":"11","author":"Zhao","year":"2019","journal-title":"MAbs"},{"key":"B41","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.str.2020.03.001","article-title":"Antigen-induced allosteric changes in a human igG1 fc increase low-affinity fc\u03b3 Receptor binding","volume":"28","author":"Orlandi","year":"2020","journal-title":"Structure"},{"key":"B42","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jaci.2019.03.028","article-title":"Role of the IgE variable heavy chain in Fc\u03f5RI\u03b1 and superantigen binding in allergy and immunotherapy","volume":"144","author":"Lua","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00022","article-title":"Ig constant region effects on variable region structure and function. Feb. 04, 2016","author":"Janda","year":"2016","journal-title":"Front Media S.A"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/antib7020020","article-title":"Allosteric effects between the antibody constant and variable regions: A study of IgA Fc mutations on antigen binding","volume":"7","author":"Su","year":"2018","journal-title":"Antibodies"},{"key":"B45","doi-asserted-by":"crossref","unstructured":"Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement\n          \n          \n            \n              Hale\n              G\n            \n            \n              Bright\n              S\n            \n            \n              Chumbley\n              G\n            \n            \n              Hoang\n              T\n            \n            \n              Metcalf\n              D\n            \n            \n              Munro\n              AJ\n            \n          \n          6349718\n          Blood\n          62\n          1983","DOI":"10.1182\/blood.V62.4.873.873"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001857","article-title":"Anti-HIV IgM protects against mucosal SHIV transmission","volume":"32","author":"Gong","year":"2018","journal-title":"AIDS"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-003-0436-1","article-title":"Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma","volume":"53","author":"Irie","year":"2004","journal-title":"Cancer Immunology Immunotherapy"},{"key":"B48","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1158\/1535-7163.MCT-06-0399","article-title":"The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoprotein","volume":"6","author":"Br\u00e4ndlein","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.045997","article-title":"Phase I trial of a novel human monoclonal antibody mab216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia","volume":"97","author":"Liedtke","year":"2012","journal-title":"Haematologica"},{"key":"B50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3324\/haematol.2014.117945","article-title":"GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6","volume":"100","author":"Rasche","year":"2015","journal-title":"Haematologica"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063414","article-title":"The natural human igM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78","volume":"8","author":"Rasche","year":"2013","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3233\/HAB-2002-11403","article-title":"Nature\u2019s best weapons to fight cancer. Revival of human monoclonal IgM antibodies","volume":"11","author":"Vollmers","year":"2003","journal-title":"Hum Antibodies"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1021\/ja303286e","article-title":"Structural determinants of the supramolecular organization of G protein-coupled receptors in bilayers","volume":"134","author":"Periole","year":"2012","journal-title":"J Am Chem Soc"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.5b08048","article-title":"Organization and dynamics of receptor proteins in a plasma membrane","volume":"137","author":"Kolds\u00f8","year":"2015","journal-title":"J Am Chem Soc"},{"key":"B55","doi-asserted-by":"crossref","unstructured":"Cripto: a novel target for antibody-based cancer immunotherapy\n          \n          \n            \n              Xing\n              PX\n            \n            \n              Hu\n              XF\n            \n            \n              Pietersz\n              GA\n            \n            \n              Hosick\n              HL\n            \n            \n              McKenzie\n              IF\n            \n          \n          10.1158\/0008-5472.CAN-03-3888\n          15173016\n          Cancer Res\n          64\n          2004","DOI":"10.1158\/0008-5472.CAN-03-3888"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.03.003","article-title":"Kussie and K. M. Ferguson., Structural basis for inhibition of the epidermal growth factor receptor by cetuximab","volume":"7","author":"Li","year":"2005","journal-title":"Cancer Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1300547110","article-title":"High-resolution structures of the IgM Fc domains reveal principles of its hexamer formation","volume":"110","author":"M\u00fcller","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.str.2017.04.014","article-title":"Fcab-HER2 interaction: a m\u00e9nage \u00e0 Trois. Lessons from X-ray and solution studies","volume":"25","author":"Lobner","year":"2017","journal-title":"Structure"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1021\/bi962514+","article-title":"Refined structure of an intact igG2a monoclonal antibody","volume":"36","author":"Harris","year":"1997","journal-title":"Biochemistry"},{"key":"B60","volume-title":"The pyMOL molecular graphics system, version~1.8","author":"Schr\u00f6dinger","year":"2015"},{"key":"B61","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"\u0160ali","year":"1993","journal-title":"J Mol Biol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73218","article-title":"A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor","volume":"10","author":"Huang","year":"","journal-title":"Elife"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.softx.2015.06.001","article-title":"Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1021\/ct9002114","article-title":"Combining an elastic network with a coarse-grained molecular force field: structure, dynamics, and intermolecular recognition","volume":"5","author":"Periole","year":"2009","journal-title":"J Chem Theory Comput"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1021\/ct700324x","article-title":"The MARTINI coarse-grained force field: extension to proteins","volume":"4","author":"Monticelli","year":"2008","journal-title":"J Chem Theory Comput"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c00495","article-title":"Extending the martini coarse-grained force field to N -glycans","volume":"60","author":"Shivgan","year":"2020","journal-title":"J Chem Inf Model"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M504528200","article-title":"Human serum IgM glycosylation: Identification of glycoforms that can bind to Mannan-binding lectin","volume":"280","author":"Arnold","year":"2005","journal-title":"J Biol Chem"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J Chem Phys"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J Chem Phys"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: A new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J Appl Phys"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.540130812","article-title":"THE weighted histogram analysis method for free-energy calculations on biomolecules. I. The method","volume":"13","author":"Kumar","year":"1992","journal-title":"J Comput Chem"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1021\/ct100494z","article-title":"g_wham\u2014A free weighted histogram analysis implementation including robust error and autocorrelation estimates","volume":"6","author":"Hub","year":"2010","journal-title":"J Chem Theory Comput"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1733907\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:38:09Z","timestamp":1767940689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1733907\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":73,"alternative-id":["10.3389\/fimmu.2025.1733907"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1733907","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"article-number":"1733907"}}